1. Home
  2. BZH vs OPK Comparison

BZH vs OPK Comparison

Compare BZH & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BZH
  • OPK
  • Stock Information
  • Founded
  • BZH 1985
  • OPK 2007
  • Country
  • BZH United States
  • OPK United States
  • Employees
  • BZH N/A
  • OPK N/A
  • Industry
  • BZH Homebuilding
  • OPK Biotechnology: Pharmaceutical Preparations
  • Sector
  • BZH Consumer Discretionary
  • OPK Health Care
  • Exchange
  • BZH Nasdaq
  • OPK Nasdaq
  • Market Cap
  • BZH 666.1M
  • OPK 1.1B
  • IPO Year
  • BZH 1994
  • OPK 1995
  • Fundamental
  • Price
  • BZH $23.17
  • OPK $1.34
  • Analyst Decision
  • BZH Strong Buy
  • OPK Buy
  • Analyst Count
  • BZH 3
  • OPK 4
  • Target Price
  • BZH $33.00
  • OPK $2.75
  • AVG Volume (30 Days)
  • BZH 297.6K
  • OPK 3.3M
  • Earning Date
  • BZH 07-31-2025
  • OPK 08-06-2025
  • Dividend Yield
  • BZH N/A
  • OPK N/A
  • EPS Growth
  • BZH N/A
  • OPK N/A
  • EPS
  • BZH 3.10
  • OPK N/A
  • Revenue
  • BZH $2,436,131,000.00
  • OPK $689,408,000.00
  • Revenue This Year
  • BZH N/A
  • OPK N/A
  • Revenue Next Year
  • BZH $14.27
  • OPK $6.98
  • P/E Ratio
  • BZH $7.46
  • OPK N/A
  • Revenue Growth
  • BZH 13.50
  • OPK N/A
  • 52 Week Low
  • BZH $17.37
  • OPK $1.21
  • 52 Week High
  • BZH $38.22
  • OPK $2.04
  • Technical
  • Relative Strength Index (RSI)
  • BZH 62.90
  • OPK 51.42
  • Support Level
  • BZH $23.86
  • OPK $1.32
  • Resistance Level
  • BZH $25.07
  • OPK $1.36
  • Average True Range (ATR)
  • BZH 0.78
  • OPK 0.04
  • MACD
  • BZH 0.12
  • OPK 0.00
  • Stochastic Oscillator
  • BZH 75.45
  • OPK 65.38

About BZH Beazer Homes USA Inc.

Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in over 13 states and over 22 metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the leading sources of revenue for the company. Key metro areas include Atlanta, Las Vegas, Los Angeles, Orlando, and Tampa. The company also focuses on land purchasing and development to support future construction efforts as well as mortgage services for its homebuyers.

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

Share on Social Networks: